Comparing one-stent with drug balloon vs. two-stents for heart artery branches
Part of Heart & circulation clinical trials.
This study compares two ways to treat a narrowed heart artery where a smaller branch vessel is also blocked. One approach uses a drug-coated balloon on the side branch, while the other places a second stent. The goal is to see which method works better for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years or older
- You have a true bifurcation lesion (narrowing at a branch point) in a heart artery that hasn't been treated before
- You have stable angina, unstable angina, or a non-ST-elevation heart attack that happened at least 24 hours ago
- You are not having a major ST-elevation heart attack or a blockage in the left main artery
- You can take aspirin and clopidogrel/ticagrelor, and you are not at high risk for bleeding
- You do not have severe liver disease, very low blood counts, or need major surgery within 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different ways of placing two drug-eluting stents for new (de novo) coronary artery blockages that split into two branches. It may help doctors choose the safest, most effective technique for patients with specific coronary anatomy.
This trial tests a new way to treat complex blockages in heart arteries where a side branch is also narrowed. It uses a drug-coated balloon to open the side branch, aiming to improve blood flow and reduce the need for repeat procedures.
This study compares two ways of opening the “side branch” of a heart artery after an initial main-branch stent. It may help doctors choose the safest, most effective approach for people whose side branch is significantly narrowed after the first stent.
This trial compares two ways to open a specific type of heart blockage that involves both a main artery and a side branch. It tests whether using a drug-coated balloon (“hybrid strategy”) works as well as using a planned two-stent approach (“stepwise provisional strategy”).
This trial compares two treatments for new blockages in heart arteries: a drug-coated balloon (a tiny balloon that delivers medicine) versus a drug-eluting stent (a small mesh tube that releases medicine). The study hopes to see which approach keeps the artery open longer and is safer over time.
This study compares two treatments for new blockages in large heart arteries: a drug-coated balloon (a balloon that releases medicine) versus a drug-coated stent (a small mesh tube). The goal is to see which one better helps the artery stay open and function normally.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.